Business Context and Reporting Period
Company: II-VI Incorporated (Note: Filing text identifies registrant as II-VI; metadata lists "COHERENT CORP." which appears to be an error in the request metadata as the text is explicitly for II-VI).
Reporting Period: Fiscal year ended June 30, 2003.
Business Overview: II-VI develops, manufactures, and markets high-technology materials and derivative products for precision use in industrial, medical, military, and aerospace applications. Key product lines include optical components for industrial lasers (CO2 and YAG), military infrared optics, solid-state radiation detectors (CdZnTe), and silicon carbide (SiC) substrates. The company operates manufacturing facilities in the U.S., Singapore, China, and Belgium, with approximately 41% of revenues derived from international sales.
Key Financial Metrics
| Metric | Fiscal 2003 | Fiscal 2002 |
|---|---|---|
| Net Revenues | $128.2 million | $113.7 million |
| Net Earnings | $11.6 million | $7.3 million |
| Diluted EPS | $0.81 | $0.51 |
| Operating Cash Flow | $25.6 million | $16.1 million |
| Manufacturing Gross Margin | 41% | 34% |
| Total Debt | $23.7 million | $34.5 million |
| Working Capital | $40.2 million | $35.7 million |
| Cash and Equivalents | $15.6 million | $9.6 million |
Material Changes vs. Prior Period
- Revenue Growth: Revenues increased 13% to $128.2 million, driven primarily by strong demand in the commercial infrared optics market and the integration of a new German distribution subsidiary (II-VI/L.O.T.).
- Profitability Surge: Net earnings rose 60% to $11.6 million. Segment earnings increased 51% to $17.2 million, attributed to improved manufacturing efficiencies, cost controls, and higher sales volume in the Infrared Optics segment.
- Debt Reduction: Total debt decreased by 31% (from $34.5 million to $23.7 million) as the company used cash flow to pay down $10.9 million in debt.
- Segment Performance:
- Infrared Optics: Revenues up 19%; Segment earnings up 57%.
- Near-Infrared Optics: Revenues flat; Segment earnings up 31% due to yield improvements.
- Military Infrared Optics: Revenues up 5%; Segment earnings turned to a loss of $0.1 million due to cost overruns on a development contract.
- Other (eV PRODUCTS/WBG): Revenues up 23%; Segment loss increased slightly to $4.4 million due to weak demand for eV PRODUCTS.
Guidance, Outlook, and Risks
Management Commentary & Outlook:
- Management expects continued growth in the infrared optics market and aims to gain market share in CO2 and YAG applications.
- The company is investing in Silicon Carbide (SiC) development, with initial product acceptance described as "very good."
- Strategy includes pursuing strategic acquisitions and alliances to expand market coverage and accelerate access to high-growth segments.
Risks and Contingencies:
- Supply Chain: Dependence on limited sources for critical raw materials (e.g., Zinc Selenide, Hydrogen Selenide). A failure of suppliers could materially adversely affect operations.
- Cyclicality: Business is dependent on cyclical industries (industrial lasers, defense). Economic downturns could reduce demand.
- Government Contracts: Military contracts are subject to funding approval and can be terminated without warning.
- Intellectual Property: Reliance on trade secrets rather than patents; risk of infringement claims or technology disclosure.
- Foreign Exchange: Significant international exposure (41% of revenue) creates risk from currency fluctuations, particularly the Japanese Yen.
Unusual Items:
- Recognition of a $1.2 million loss on a fixed-price development contract in the Military Infrared Optics segment.
- Acquisition of a 75% interest in II-VI/L.O.T. GmbH for $2.8 million to consolidate German distribution.
Investor Verification Checklist
- Segment Margin Sustainability: Verify if the 41% manufacturing gross margin is sustainable given the mix shift toward lower-margin military contracts.
- SiC Commercialization: Assess the timeline and revenue potential for the Silicon Carbide (SiC) substrate business, which is currently in early commercial stages.
- Customer Concentration: Review the dependency on the single European distributor for a significant portion of non-subsidiary European sales.
- Debt Covenants: Confirm compliance with restrictive covenants in the $45 million credit facility (minimum net worth, leverage, interest coverage).
- Inventory Levels: Monitor inventory growth ($24.4 million in 2003 vs $19.7 million in 2002) relative to sales to ensure no obsolescence risks in the slow-moving reserve.